Article
Design and Synthesis of Melanocortin Peptides with Candidacidal and Anti-TNF-α Properties
Università di Napoli.
Division of Internal Medicine, Ospedale Maggiore di Milano IRCCS.
Division of Liver Transplantation, Ospedale Maggiore di Milano IRCCS.
Zengen Inc.
Corresponding author: Anna Catania, M. D., Divisione di Medicina Interna 1, Padiglione Granelli, Ospedale Maggiore di Milano IRCCS, Via F. Sforza 35, 20122 Milano, Italy. E-mail anna.catania@ unimi.it. Tel/FAX +39 02 5503 3318.
Abstract

α-Melanocyte stimulating hormone (α-MSH) is an endogenous antiinflammatory peptide with antimicrobial properties. We recently found that a synthetic analogue, [dNal(2‘)-7, Phe-12]-α-MSH (6−13), was considerably more potent in killing Candida albicans, but the anti-cytokine potential of the molecule was not investigated. Because molecules that combine candidacidal and antiinflammatory properties could be very useful in clinical practice, we measured the anti-TNF-α potential of [dNal(2‘)-7, Phe-12]-α-MSH (6−13) and explored effects of amino acid deletions and substitutions on both anti-Candida and anti-TNF-α activities. The results show that anti-TNF-α properties of this candidacidal peptide are only marginally increased relative to the native sequence. Conversely, we found that a closely related candidacidal analogue, [dNal(2‘)-7, Pro-12]-α-MSH (6−13), had enhanced anti-TNF-α effects in vitro and in vivo. This peptide, and other melanocortins with a similar dual effect, could be very useful to eradicate infections and, concurrently, reduce inflammatory reactions.
View: Full Text HTML | Hi-Res PDF
Tools
-
Add to Favorites
-
Download Citation
-
Email a Colleague -
Permalink
Order Reprints
Rights & Permissions
Citation Alerts
History
- Published In Issue March 10, 2005
- Received October 20, 2004
Cart



